INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Sutherland Everett Rand reported KRYS

Director · Krystal Biotech, Inc. · Krystal Biotech, Inc. — Restricted Stock Units

Side
A
Value
—
Shares
471
Price
—
Executed
Sep 14, 2026
Disclosed
Sep 16, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 14 executedSep 16, 2026 disclosed

KRYS · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · KRYS

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    MC
    Mason ChristopherDirector
    KRYSKrystal Biotech, Inc.
    Grant or award
    		A—
    471 sh
    		Sep 14, 2026Sep 16, 2026
    traded Sep 14, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MC
    Mason ChristopherDirector
    KRYSKrystal Biotech, Inc.
    Grant or award
    		A—
    1,187 sh
    		Sep 14, 2026Sep 16, 2026
    traded Sep 14, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MC
    Mazzacco CatherineDirector
    KRYSKrystal Biotech, Inc.
    Grant or award
    		A—
    1,187 sh
    		Sep 14, 2026Sep 16, 2026
    traded Sep 14, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MC
    Mazzacco CatherineDirector
    KRYSKrystal Biotech, Inc.
    Grant or award
    		A—
    471 sh
    		Sep 14, 2026Sep 16, 2026
    traded Sep 14, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SR
    Sutherland Everett RandDirector
    KRYSKrystal Biotech, Inc.
    Grant or award
    		A—
    1,187 sh
    		Sep 14, 2026Sep 16, 2026
    traded Sep 14, 2026
    		+2dSEC FORM 4

    Evidence

    0
    TC
    Thomas John CharlesEVP, General Counsel
    KRYSKrystal Biotech, Inc.
    Option exercise · 10b5-1 plan
    		M—
    1,000 sh
    		Jun 25, 2026Jun 26, 2026
    traded Jun 25, 2026
    		+1dSEC FORM 4

    Evidence

    0
    TC
    Thomas John CharlesEVP, General Counsel
    KRYSKrystal Biotech, Inc.
    Option exercise · 10b5-1 plan
    		M$179K
    1,000 sh
    		Jun 25, 2026Jun 26, 2026
    traded Jun 25, 2026
    		+1dSEC FORM 4

    Evidence

    19
    TC
    Thomas John CharlesEVP, General Counsel
    KRYSKrystal Biotech, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$347K
    1,000 sh
    		Jun 25, 2026Jun 26, 2026
    traded Jun 25, 2026
    		+1dSEC FORM 4

    Evidence

    20
    TC
    Thomas John CharlesEVP, General Counsel
    KRYSKrystal Biotech, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$194K
    642 sh
    		May 26, 2026May 27, 2026
    traded May 26, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001852880-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 14, 2026
    Published
    Sep 16, 2026
    Ingested by INSIDER
    Nov 5, 02:16 UTC
    Last re-read
    Nov 5, 02:16 UTC

    Extracted facts

    Filer
    Sutherland Everett Rand
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Krystal Biotech, Inc. — Restricted Stock Units
    Ticker
    KRYS
    Shares
    471
    Price per share
    $0
    Execution date (reported)
    Sep 14, 2026
    Owned after transaction
    471 shares
    Days from execution to publication
    2

    What this establishes

    Sutherland Everett Rand filed this Form 4 reporting a grant or award of KRYS on Sep 14, 2026. It became public on Sep 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Sutherland Everett Randcik:0001852880
    Issuer
    Krystal Biotech, Inc.cik:0001711279

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.